Companies Cryptocurrencies
Avalon Globocare Corp
Avalon Globocare Corp
Exchange: NasdaqCM
IPO Date: 22/02/2016
CEO: Dr. David K. Jin
Medical Care Facilities Healthcare 🔗
  • AVCO
  • 0.99
  • 84551848
    market cap
  • -0.01999998
If you bought

shares of Avalon Globocare Corp (AVCO) on
You would have made
Old Price $12 Current Price $12

Avalon GloboCare Corp. is a holding company, which engages in the development of biotechnology and provision of healthcare services. The company is headquartered in Freehold, New Jersey and currently employs 8 full-time employees. The firm engages in the management of stem cell banks and specialty clinical laboratories. The company is developing of exosome technology to improve the diagnosis and management of diseases. The firm operates through two platforms, Avalon Cell and Avalon Rehab. Its technology and service ecosystem covers the areas of regenerative medicine, cell-based immunotherapy, exosome technology, as well as rehabilitation medicine. The firm also focused on diagnostic advancements in the fields of oncology, infectious diseases and fibrotic diseases, and the discovery of disease-specific exosomes to provide the disease origin insight necessary to enable.

Address: 4400 US Highway 9 Ste 3100 Freehold NEW JERSEY 07728

Stay updated.